# Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

> **NCT04263584** · PHASE2 · UNKNOWN · sponsor: **University Hospital Muenster** · enrollment: 62 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **DRUG:** Copanlisib
- **DRUG:** R-CHOP Chemotherapy

## Key facts

- **NCT ID:** NCT04263584
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-19
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04263584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04263584, "Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04263584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*